Anders provides expertise within health economics, market access, pricing and reimbursement processes within MedTech.
Prior to joining Nordic HTA, Anders Mærkedahl was Global head of Health Economics & Market Access at Ambu A/S, responsible for the integration of health economics into product development (stage-gate model), clinical development plans, and launch excellence plans. Anders established the global HEMA team in Ambu A/S and built it from 1 to now more than 15 people globally. Anders is an expert within implementation of value-based procurement, developing key health economic and market access tools (BIA, CEA, GPO- IDN strategy tools and value dossiers) within MedTech. Anders is currently representing the Danish MedTech industry in a commission under the Danish Ministry of Industry, Business & Financial Affairs and the Ministry of Health; “Partnership for Innovation Promoting Health Care in Medical Devices” as an expert within HEMA.
Anders holds a Msc in Medical Market Access and a BSc in Medicine with Industrial Specialization from Aalborg University, Denmark.